Surgical Treatments for Vasculogenic Erectile Dysfunction

  • Michael A. Palese
  • John P. Mulhall
  • Irwin Goldstein


Vasculogenic erectile dysfunction can be corrected, and the options include penile revascularization surgery, crural ligation surgery for the treatment of focal veno-occlusive dysfunction, and the development of pharmacologic and biologic neovascularization agents. During the past several decades, numerous reports in the literature have attempted to detail refinements in all of these techniques.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Zumbe J, Drawz G, Widemann A, et al.: Indications for penile revascularization and long term results. Andrologia 1999, 315: 83–87.Google Scholar
  2. 2.
    Manning M, Junemann K-P, Pospichal J, et al.: Long-term follow-up and selection criteria for penile revascularization in erectile failure. J Urol 1998, 160: 1680–1684.PubMedCrossRefGoogle Scholar
  3. 3.
    Sarramon JP, Bertrand N, Malavaud B, et al.: Microrevascularization of the penis in vascular impotence. Intl Impot Res 1997, 9: 127–131.CrossRefGoogle Scholar
  4. 4.
    Anafarta K, Aydos K, Yaman O: Is deep dorsal vein arterialization an alternative surgical approach to treat venogenic impotence? Urol Int 1997, 59: 109–113.PubMedCrossRefGoogle Scholar
  5. 5.
    Jarow JP, DeFranzo AJ: Long-term results of arterial bypass surgery for impotence secondary to segmental vascular disease. J Urol 1996, 156: 982–987.PubMedCrossRefGoogle Scholar
  6. 6.
    DePalma RG, Olding M, Yu GW, et al.: Vascular interventions for impotence: lessons learned. J Vasc Surg 1995, 21: 576–580.CrossRefGoogle Scholar
  7. 7.
    Rogers RS, Lue TF: Penile venous surgery benefits patients under 40 years of age. J Urol 1999, 161: 258–261.CrossRefGoogle Scholar
  8. 8.
    Lue TF: Surgery for crural venous leakage. Urology 1999, 54: 739–741.PubMedCrossRefGoogle Scholar
  9. 9.
    Muthall JP, Martin D, Ergin E, et al.: Crural ligation surgery for the young male with venogenic erectile dysfunction: technique. Tech Urol 2001, 7: 290–293.Google Scholar
  10. 10.
    Byrne RR, Henry GD, Rao DS, et al.: Vascular endothelial growth factor restores corporeal smooth muscle function in vitro. J Urol 2001, 165: 1310–1315.PubMedCrossRefGoogle Scholar
  11. 11.
    Lee MC, El-Sakka AI, Graziottin TM, et al.: The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002, 167: 761–766.PubMedCrossRefGoogle Scholar
  12. 12.
    Gholami SS, Rogers R, Chang J, et al.: The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003, 169: 1577–1581.PubMedCrossRefGoogle Scholar
  13. 13.
    Goldstein I: Vascular diseases of the penis. In Clinical Urography. Edited by Pollack H. Philadelphia: WB Saunders; 1990: 2231–2252.Google Scholar
  14. 14.
    Krane RJ, Goldstein I, Saenz de Tejada I: Impotence. N Engl Med J 1989, 321: 1648–1659.CrossRefGoogle Scholar
  15. 15.
    Michal V, Kramar R, Pospichal J, et al.: Direct arterial anastomosis on corpora cavernosa penis in the therapy of erective impotence. Rozhl Chir 1973, 52: 587–590.PubMedGoogle Scholar
  16. 16.
    Michael V, Kramar R, Pospichal J, et al.: Vascular surgery in the treatment of impotence: its present possibilities and prospects. Czech Med 1980, 3: 213–217.Google Scholar
  17. 17.
    Virag R, Zwang G, Dermange H, et al.: Vasculogenic impotence: a review of 92 cases with 54 surgical operations. Vasc Surg 1981, 15: 9–13.CrossRefGoogle Scholar
  18. 18.
    Hauri D: Therapiemoglichkeiten bei der vascular bedinkten erekteilen impotenz. Akt Urol 1984, 15: 350–354.CrossRefGoogle Scholar
  19. 19.
    Crespo EI, Bove D, Farrell C, et al.: Microvascular surgery technique and follow up. Vasc Surg 1987, 21: 277–281.CrossRefGoogle Scholar
  20. 20.
    Carmignani G, Pirozzi F, Corbu C, et al.: Cavernous artery revascularization in vasculogenic impotence: new simplified technique. Urology 1987, 30: 23–27.PubMedCrossRefGoogle Scholar
  21. 21.
    Goldstein I: Overview of types and results of vascular surgical procedures for impotence. Cardiovasc Intervent Radiol 1988, 11: 240–244.PubMedCrossRefGoogle Scholar
  22. 22.
    Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 1995, 333: 1757–1767.PubMedCrossRefGoogle Scholar
  23. 23.
    Losordo DW, Vale PR, Symes JF, et al.: Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998, 98: 2800–2808.PubMedCrossRefGoogle Scholar
  24. 24.
    Baumgartner I, Pieczek A, Manor O, et al.: Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998, 97: 1114–1120.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Michael A. Palese
  • John P. Mulhall
  • Irwin Goldstein

There are no affiliations available

Personalised recommendations